Inducers of Senescence, Toxic Compounds, and Senolytics: The Multiple Faces of Nrf2-Activating Phytochemicals in Cancer Adjuvant Therapy
The reactivation of senescence in cancer and the subsequent clearance of senescent cells are suggested as therapeutic intervention in the eradication of cancer. Several natural compounds that activate Nrf2 (nuclear factor erythroid-derived 2-related factor 2) pathway, which is involved in complex cy...
Saved in:
| Main Authors: | Marco Malavolta, Massimo Bracci, Lory Santarelli, Md Abu Sayeed, Elisa Pierpaoli, Robertina Giacconi, Laura Costarelli, Francesco Piacenza, Andrea Basso, Maurizio Cardelli, Mauro Provinciali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2018/4159013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted delivery of liposomal senolytics to alleviate cellular senescence-induced bone loss
by: Rong Li, et al.
Published: (2025-07-01) -
Development and Application of a Senolytic Predictor for Discovery of Novel Senolytic Compounds and Herbs
by: Jinjun Li, et al.
Published: (2025-06-01) -
The adverse effects of chemotherapy on bone mass are not prevented by senolytics
by: Md Mohsin Ali, et al.
Published: (2025-05-01) -
Modeling treatment of diabetic wounds with oxygen therapy and senolytic drug
by: Nourridine Siewe, et al.
Published: (2025-05-01) -
Senolytic Interventions for Type 2 Diabetes: Current Evidence and Future Directions
by: Selene Sodini, et al.
Published: (2025-06-01)